Pliant Therapeutics, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
0.09 |
2.86 |
3.00 |
68.42 |
361.78 |
669.94 |
| Przychód Δ r/r |
0.00% |
3042.86% |
5.00% |
2180.83% |
428.73% |
85.18% |
| Przychód (min) |
0.09 |
2.86 |
3.00 |
68.42 |
361.78 |
669.94 |
| Przychód (max) |
0.09 |
2.86 |
3.00 |
68.42 |
361.78 |
669.94 |
| EBITDA (średnia) |
-0.05 |
-1.69 |
-1.78 |
-40.57 |
-214.51 |
-397.21 |
| EBIT (średnia) |
-0.05 |
-1.71 |
-1.80 |
-41.00 |
-216.77 |
-401.41 |
| EBIT % |
-59.92% |
-59.92% |
-59.92% |
-59.92% |
-59.92% |
-59.92% |
| Zysk netto (średni) |
-215.43 |
-149.48 |
-164.85 |
-160.90 |
9.08 |
139.84 |
| Zysk netto % |
-236975.65% |
-5231.89% |
-5495.07% |
-235.14% |
2.51% |
20.87% |
| EPS (średnia) |
-3.56 |
-2.47 |
-1.91 |
-1.13 |
0.15 |
2.31 |
| Liczba analityków (Przychody) |
11 |
11 |
11 |
8 |
6 |
7 |
| Liczba analityków (EPS) |
9 |
8 |
10 |
7 |
5 |
2 |
| symbol |
PLRX |
PLRX |
PLRX |
PLRX |
PLRX |
PLRX |